Clinical Trials List
2023-12-01 - 2028-12-31
Phase I
Recruiting2
ICD-10C34.90
Malignant neoplasm of unspecified part of unspecified bronchus or lung
ICD-10C34.91
Malignant neoplasm of unspecified part of right bronchus or lung
ICD-10C34.92
Malignant neoplasm of unspecified part of left bronchus or lung
ICD-10C7A.090
Malignant carcinoid tumor of the bronchus and lung
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9162.9
Malignant neoplasm of bronchus and lung, unspecified
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- 吳宗哲 Division of Hematology & Oncology
- James Chih-Hsin Yang Division of Hematology & Oncology
- 蔡子修 Division of Hematology & Oncology
- CHAO-CHI HO CHAO-CHI HO Division of Hematology & Oncology
- YEN-TING LIN Division of Hematology & Oncology
- 許嘉林 Division of Hematology & Oncology
- 廖斌志 Division of Hematology & Oncology
- Jih-Hsiang Lee Division of Hematology & Oncology
- 徐偉勛 Division of Hematology & Oncology
- 廖唯昱 Division of Hematology & Oncology
- 吳尚俊 Division of Hematology & Oncology
- JIN-YUAN SHIH Division of Hematology & Oncology
- 楊景堯 Division of Hematology & Oncology
- 林昭文 Division of Ophthalmology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 張毓帆 Division of Ophthalmology
- Hsu-ching Huang Division of Thoracic Medicine
- Chia-I Shen Division of Hematology & Oncology
- YEN-HAN TSENG Division of Hematology & Oncology
- 蕭慈慧 Division of Thoracic Medicine
- Chi-Lu Chiang Division of Hematology & Oncology
- Yuh-Min Chen Division of Hematology & Oncology
- 趙恒勝 Division of Thoracic Medicine
- 郭懿萱 Division of Ophthalmology
- 廖映庭 Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
31 participants
-
Global
251 participants